SlideShare a Scribd company logo
The challenges of regulating direct
to consumer digital medical devices
Dr Elizabeth McGrath
Director Emerging Technologies
Medical Devices and Product Quality Division
ARCS Annual Conference
6 August 2019
• What are digital medical devices?
• What is the Role of the Regulator?
• What are the Challenges in Applying the Framework to Digital Devices?
• What are Some International Approaches?
• What is the TGA doing?
• Questions
1
What are digital medical devices?
• Connected medical devices
• Telehealth
• Machine learning and AI
• Mobile health
• Smart medical device
• Phone & tablet apps
• Medical imaging
• Electronic medical or health records
• Medical software
• Sensors and wearables
• Big health data and analytics
• DIY medical devices
Part of the digital health ecosystem 2
Enablers of DTC digital medical devices
• Technology advances (sensor technology/computing
platforms)
• Accessibility of solutions and computing platforms (app
stores/ smartphones and tablets)
• Uptake of technology by consumers
• Low barriers to entry for industry (programming =
manufacturing - no capital investment)
3
Examples of DTC digital medical devices
• Smartphone Pulse Oximeters
• Smartphone EKG devices
• Smartphone ultrasound devices
• Apps for calculating medicine dosages
• Apps for tracking chronic disease parameters
• Apps for treating behavioural issues
4
Examples of DTC medical-device-like consumer goods
• Activity trackers
• Sleep monitors
• Heart rate monitors for exercise
• Apps for exercise programs
• Apps for recording dietary intake
• Apps for reducing stress
5
Benefits of DTC digital medical devices
• Consumers are more engaged with their
health
• Chronic disease suffers can better manage
their conditions
• Healthcare providers have access to more
patient data
• Bigger data sets for population health
6
Issues with DTC digital medical devices
https://www.mobihealthnews.com/6594/consumer-ultrasound-dangerous-
idiotic-irresponsible
https://www.sciencedaily.com/releases/2017/05/170503092146.htm
https://www.statnews.com/2019/07/24/fitbit-accuracy-dark-skin/
tga.gov.au
https://www.medpagetoday.com/Blogs/IltifatHusain/51888 7
• What are digital medical devices?
• What is the Role of the Regulator?
• What are the Challenges in Applying the Framework to Digital Devices?
• What are Some International Approaches?
• What is the TGA doing?
• Questions
8
The role of the TGA
• The TGA, part of the Department of Health and Ageing, was established in 1989 as the main Australian
Government entity responsible for ensuring that medicines and medical devices used by Australian
consumers are evaluated and regulated before they reach the market and monitored once they are in use.
• About the work of the TGA – a risk management approach
– Australian can expect the medicines and medical devices they use to meet an acceptable level of safety
and quality.
• Therapeutic product vigilance
– The work of the TGA is to ensure that the benefits to consumers outweigh any risks associated with the
use of medicines, medical devices and biologicals.
9
Regulatory requirements for medical devices
• Does it Fit the Definition of a Medical Device?
• Apply the Classification Rules
• Evidence of Quality, Safety and Performance
• Regulatory Review of Evidence (if device is above Class I)
• Manufacturing Certification (if device is above Class I)
• Inclusion in the ARTG
• Post Market Requirements
– Monitor Post Market Performance
– Report Problems to the TGA
– Annual Manufacturing Inspections
10
What is a medical device?
Defined in s41BD of the Therapeutic Goods Act 1989
1 (a) Any instrument, apparatus, appliance, material or other article
intended to be used for human beings for the purpose of one or more of
the following
(i) diagnosis, prevention, monitoring, treatment or alleviation of disease;
(ii) diagnosis, monitoring, treatment, alleviation of or compensation for an
injury or disability
(iii) investigation, replacement or modification of the anatomy or of a
physiological process
(iv) control of conception;
and that does not achieve its principal intended action in or on the human
body by pharmacological, immunological or metabolic means, but that
may be assisted in its function by such means
Bandages
Dental implant
Breast implant
Glucose monitor
11
What is a medical device? (continued)
Defined in s41BD of the Therapeutic Goods Act 1989
(2) For the purposes of paragraph (1)(a), the purpose for which an instrument, apparatus,
appliance, material or other article (the main equipment) is to be used is to be ascertained
from the information supplied, by the person under whose name the main equipment is or is
to be supplied, on or in any one or more of the following:
(a) the labelling on the main equipment;
(b) the instructions for using the main equipment;
(c) any advertising material relating to the main equipment;
(d) technical documentation describing the mechanism of action of the main equipment.
12
Risk based classification
Risk
classification
is based on:
Intended use of
the device
Potential to Harm
patients, users
and other persons
Degree of
invasiveness in
the human body
Location and
Duration of use
13
Regulatory oversight increases with increasing risk category
Regulatory Scrutiny
✔✔✔✔
✔✔✔
✔✔
✔
Class III
Class IIb
Class IIa
Class ILow Risk
High Risk
(IVD Device Classes – Class 1 to Class 4)
The Essential Principles
General principles
1. Use of medical devices not to compromise
health and safety
2. Design and construction of medical devices to
conform to safety principles
3. Medical devices to be suitable for intended
purpose
4. Long-term safety
5. Medical devices not to be adversely affected
by transport or storage
6. Benefits of medical devices to outweigh any
side effects
Principles about design and construction
7. Chemical, physical and biological properties
8. Infection and microbial contamination
9. Construction and environmental properties
10.Medical devices with a measuring function
11.Protection against radiation
12.Medical devices connected to or equipped with an
energy source
13.Information to be provided with medical devices
14.Clinical evidence
15.Principles applying to IVD medical devices only
Therapeutic Goods (Medical Devices) Regulations 2002, Schedule 1
www.legislation.gov.au
15
What is clinical evidence for a medical device?
https://www.tga.gov.au/sites/default/files/clinical-evidence-guidelines-medical-devices.pdf
16
Inclusion in the ARTG
Class I:
Self-assessment and declaration
Class Is, Im, IIa:
Manufacturing certification including technical file review
Class IIb:
Manufacturing certification including technical file review
Mandatory application audit for some Class IIb devices
Class III:
Manufacturing certification
Device design examination certification
Mandatory application audit
Evidence requirements
Postmarket obligations
Monitoring of product
performance
Adverse event reporting
to the TGA
For higher risk devices:
AIMD, Class III or
implantable Class IIb
device
Annual reports to the
TGA required
Environmental scanning
Review of medical &
scientific literature,
regulatory news, media
and other sources
19
• What are digital medical devices?
• What is the Role of the Regulator?
• What are the Challenges in Applying the Framework to Digital Devices?
• What are Some International Approaches?
• What is the TGA doing?
• Questions
Is it regulated as a medical device?
A product is regulated by the TGA when it meets the definition of a medical device.
That is, when the legal manufacturer intends for the product to be used for:
 diagnosis,
 prevention,
 monitoring,
 treatment, or
 alleviation, of disease, injury or disability
Software is regulated by the TGA…
• When it is part of a hardware medical device or medical device system
• When it controls a medical device
• When it meets the definition of a medical device.
20
Software as a Medical Device (SaMD)
Software that is intended to run on general purpose computing platforms and is also a
medical device1
• Platforms could include computers, tablets, phones, web browsers
• Examples:
– Image processing for diagnosis or pathology
– Software that collects information and makes
a clinical decision or referral
– Apps that calculate drug dose
1. As defined in 41BD of the Therapeutic Goods Act 1989.
21
Software as a Medical Device (SaMD)
• Does not include:
– general health and lifestyle apps (not a MD)
– software that is part of a device (not regulated separately)
– apps that control a medical device (accessory and MD)
– apps that rely on hardware in addition to a general purpose computing platform,
eg – sensors, to achieve their intended purpose
22
Current classification rules for software
4.1 Active medical devices - general
An active medical device is classified as Class I, unless the device is classified at a higher level under another
clause in this Part or in Part 2, 3 or 5.
Regulation 3.3
(5) If a medical device is driven, or influenced, by an item of software, the software has the same classification
as the medical device.
Most software is Class I under the current rules
23
Challenges for regulating DTC digital devices
• Gaps in the current framework
• Interpretation of ‘intended purpose’ to determine regulatory
status
• “Off-label use” of medical-device-like consumer goods
• Consumer expectation for medical device = consumer good
• New industry players unfamiliar with medical device
regulation
• Variable levels of consumer health literacy
24
25
• What are digital medical devices?
• What is the Role of the Regulator?
• What are the Challenges in Applying the Framework to Digital Devices?
• What are Some International Approaches?
• What is the TGA doing?
• Questions
International digital device regulation
26
International digital device regulation
Recent Regulatory Reforms
• Europe
– Higher Classification for Software that provides information for clinical decision making,
– New general safety and performance requirements for software
• FDA
– New medical device definition with details for software
– Premarket assessment and certification of manufacturers for software products
• Australia
– Recent consultation for regulatory reforms for software
27
New requirements in Europe
• The EU MDR 2017/745 has introduced the following new classifications for software:
• Software that provides information to be used in making decisions for diagnosis or treatment is:
– Class III if the decisions have an impact that may cause death or an irreversible deterioration of a person’s
state of health
– Class IIb if the decisions have an impact that may cause a serious deterioration of a person’s state of
health or a surgical intervention
– Class IIa in any other case
NOTE: The EU already has an additional classification rule applicable to software compared with Australia:
Rule 16 (MDD 93/42/EEC)
Devices specifically intended for recording of X-ray diagnostic images are in Class IIa.
28
New requirements in the USA
29
New requirements in the USA
https://www.fda.gov/medicaldevices/digitalhealth/digitalhealthprecertprogram/default.htm#program
30
• What are digital medical devices?
• What is the Role of the Regulator?
• What are the Challenges in Applying the Framework to Digital Devices?
• What are Some International Approaches?
• What is the TGA doing?
• Questions
31
Proposed new requirements in Australia
• New rules to appropriately classify SaMD
products according to the potential harm they
could cause to patients
• Exclude SaMD products from the personal
importation provisions so that SaMD products
will be required to be included in the ARTG and
have an Australian sponsor
• Ensure the essential principles for medical
devices include clear and transparent
requirements for demonstrating the safety and
performance of SaMD and other regulated
software.
https://www.tga.gov.au/consultation/consultation-regulation-software-including-software-medical-device-samd
32
Next steps
Consultation on software reforms
• Consultation 14 February to 31 March 2019
• 41 Submissions, broad support for the proposals
• Revised proposals based on feedback
• Stakeholder workshop 24 June 2019 for
additional feedback
• Policy approval
• Drafting, approval and publication of regulations
• Identify carve outs for certain software categories
• Stakeholder engagement and education
• Regulatory guidance for new legislation 33
Website references and contacts
Medical device regulation basics: http://www.tga.gov.au/medical-devices-regulation-basics
Regulation of Software as a Medical Device (SaMD): https://www.tga.gov.au/regulation-software-medical-device
Premarket medical device enquiries: devices@tga.gov.au
The TGA’s Digital Devices team: digital.devices@tga.gov.au
34
• Questions
35
The challenges of regulating direct to consumer digital medical devices

More Related Content

What's hot

What's hot (20)

Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
 
Presentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & APresentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & A
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
 
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
 
Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
Presentation: Therapeutic Goods Advertising Code (No. 2) 2018Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 
Presentation: Increasing post-market vigilance requirements for medical devices
Presentation: Increasing post-market vigilance requirements for medical devicesPresentation: Increasing post-market vigilance requirements for medical devices
Presentation: Increasing post-market vigilance requirements for medical devices
 
Spotlight on MMDR Further Reviews and Advertising Reforms
Spotlight on MMDR Further Reviews and Advertising ReformsSpotlight on MMDR Further Reviews and Advertising Reforms
Spotlight on MMDR Further Reviews and Advertising Reforms
 
Presentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence GuidelinesPresentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence Guidelines
 
TGA Presentation: TGA’s Role in Clinical Trials Regulation and Administration
TGA Presentation: TGA’s Role in Clinical Trials Regulation and AdministrationTGA Presentation: TGA’s Role in Clinical Trials Regulation and Administration
TGA Presentation: TGA’s Role in Clinical Trials Regulation and Administration
 
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
 
Presentation: CMA Advertising Seminar
Presentation: CMA Advertising SeminarPresentation: CMA Advertising Seminar
Presentation: CMA Advertising Seminar
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Biovigilance
BiovigilanceBiovigilance
Biovigilance
 
TGA Presentation: What’s happening in regulation?
TGA Presentation: What’s happening in regulation?TGA Presentation: What’s happening in regulation?
TGA Presentation: What’s happening in regulation?
 
TGA Presentation: Pharmacovigilance inspections
TGA Presentation: Pharmacovigilance inspectionsTGA Presentation: Pharmacovigilance inspections
TGA Presentation: Pharmacovigilance inspections
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
 
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
 
Presentation: Conformity assessment evidence
Presentation: Conformity assessment evidencePresentation: Conformity assessment evidence
Presentation: Conformity assessment evidence
 

Similar to The challenges of regulating direct to consumer digital medical devices

Ce marking apps health 2.0 24 juli 2013
Ce marking apps health 2.0 24 juli 2013Ce marking apps health 2.0 24 juli 2013
Ce marking apps health 2.0 24 juli 2013
Sofie van der Meulen
 

Similar to The challenges of regulating direct to consumer digital medical devices (20)

TGA webinar presentation: Regulation of software, including software as a med...
TGA webinar presentation: Regulation of software, including software as a med...TGA webinar presentation: Regulation of software, including software as a med...
TGA webinar presentation: Regulation of software, including software as a med...
 
Regulation of software as medical devices
Regulation of software as medical devicesRegulation of software as medical devices
Regulation of software as medical devices
 
MHRA - 18th March 2014
MHRA - 18th March 2014MHRA - 18th March 2014
MHRA - 18th March 2014
 
Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...
 
Digital Therapeutics Regulatory Process, Update and Trends
Digital Therapeutics Regulatory Process, Update and TrendsDigital Therapeutics Regulatory Process, Update and Trends
Digital Therapeutics Regulatory Process, Update and Trends
 
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
 
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
 
Medical devices
Medical devicesMedical devices
Medical devices
 
Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)
 
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
 
Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)
 
The regulation of software: Medicines, biologicals, blood, tissues and devices
The regulation of software: Medicines, biologicals, blood, tissues and devicesThe regulation of software: Medicines, biologicals, blood, tissues and devices
The regulation of software: Medicines, biologicals, blood, tissues and devices
 
Webinar presentation: The Role of Digital Health
Webinar presentation: The Role of Digital HealthWebinar presentation: The Role of Digital Health
Webinar presentation: The Role of Digital Health
 
Presentation: Navigating regulation
Presentation: Navigating regulation Presentation: Navigating regulation
Presentation: Navigating regulation
 
Safety monitoring and reporting of adverse events of medical devices national...
Safety monitoring and reporting of adverse events of medical devices national...Safety monitoring and reporting of adverse events of medical devices national...
Safety monitoring and reporting of adverse events of medical devices national...
 
Ce marking apps health 2.0 24 juli 2013
Ce marking apps health 2.0 24 juli 2013Ce marking apps health 2.0 24 juli 2013
Ce marking apps health 2.0 24 juli 2013
 
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICESREGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
 
DTx Development
DTx DevelopmentDTx Development
DTx Development
 
160428_WP_Medical_UDI_EN.PDF
160428_WP_Medical_UDI_EN.PDF160428_WP_Medical_UDI_EN.PDF
160428_WP_Medical_UDI_EN.PDF
 
Medical Device Regulation
Medical Device RegulationMedical Device Regulation
Medical Device Regulation
 

More from TGA Australia

More from TGA Australia (12)

Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...
 
Presentation: Implementing TGO 101
Presentation: Implementing TGO 101Presentation: Implementing TGO 101
Presentation: Implementing TGO 101
 
Presentation: Advertising therapeutic goods to consumers
Presentation: Advertising therapeutic goods to consumers Presentation: Advertising therapeutic goods to consumers
Presentation: Advertising therapeutic goods to consumers
 
Presentation: Periodic safety update reports
Presentation: Periodic safety update reportsPresentation: Periodic safety update reports
Presentation: Periodic safety update reports
 
Presentation: Risk Management Plan compliance monitoring
Presentation: Risk Management Plan compliance monitoringPresentation: Risk Management Plan compliance monitoring
Presentation: Risk Management Plan compliance monitoring
 
Presentation: Risk Minimisation
Presentation: Risk MinimisationPresentation: Risk Minimisation
Presentation: Risk Minimisation
 

Recently uploaded

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
MedicoseAcademics
 

Recently uploaded (20)

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feel
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 

The challenges of regulating direct to consumer digital medical devices

  • 1. The challenges of regulating direct to consumer digital medical devices Dr Elizabeth McGrath Director Emerging Technologies Medical Devices and Product Quality Division ARCS Annual Conference 6 August 2019
  • 2. • What are digital medical devices? • What is the Role of the Regulator? • What are the Challenges in Applying the Framework to Digital Devices? • What are Some International Approaches? • What is the TGA doing? • Questions 1
  • 3. What are digital medical devices? • Connected medical devices • Telehealth • Machine learning and AI • Mobile health • Smart medical device • Phone & tablet apps • Medical imaging • Electronic medical or health records • Medical software • Sensors and wearables • Big health data and analytics • DIY medical devices Part of the digital health ecosystem 2
  • 4. Enablers of DTC digital medical devices • Technology advances (sensor technology/computing platforms) • Accessibility of solutions and computing platforms (app stores/ smartphones and tablets) • Uptake of technology by consumers • Low barriers to entry for industry (programming = manufacturing - no capital investment) 3
  • 5. Examples of DTC digital medical devices • Smartphone Pulse Oximeters • Smartphone EKG devices • Smartphone ultrasound devices • Apps for calculating medicine dosages • Apps for tracking chronic disease parameters • Apps for treating behavioural issues 4
  • 6. Examples of DTC medical-device-like consumer goods • Activity trackers • Sleep monitors • Heart rate monitors for exercise • Apps for exercise programs • Apps for recording dietary intake • Apps for reducing stress 5
  • 7. Benefits of DTC digital medical devices • Consumers are more engaged with their health • Chronic disease suffers can better manage their conditions • Healthcare providers have access to more patient data • Bigger data sets for population health 6
  • 8. Issues with DTC digital medical devices https://www.mobihealthnews.com/6594/consumer-ultrasound-dangerous- idiotic-irresponsible https://www.sciencedaily.com/releases/2017/05/170503092146.htm https://www.statnews.com/2019/07/24/fitbit-accuracy-dark-skin/ tga.gov.au https://www.medpagetoday.com/Blogs/IltifatHusain/51888 7
  • 9. • What are digital medical devices? • What is the Role of the Regulator? • What are the Challenges in Applying the Framework to Digital Devices? • What are Some International Approaches? • What is the TGA doing? • Questions 8
  • 10. The role of the TGA • The TGA, part of the Department of Health and Ageing, was established in 1989 as the main Australian Government entity responsible for ensuring that medicines and medical devices used by Australian consumers are evaluated and regulated before they reach the market and monitored once they are in use. • About the work of the TGA – a risk management approach – Australian can expect the medicines and medical devices they use to meet an acceptable level of safety and quality. • Therapeutic product vigilance – The work of the TGA is to ensure that the benefits to consumers outweigh any risks associated with the use of medicines, medical devices and biologicals. 9
  • 11. Regulatory requirements for medical devices • Does it Fit the Definition of a Medical Device? • Apply the Classification Rules • Evidence of Quality, Safety and Performance • Regulatory Review of Evidence (if device is above Class I) • Manufacturing Certification (if device is above Class I) • Inclusion in the ARTG • Post Market Requirements – Monitor Post Market Performance – Report Problems to the TGA – Annual Manufacturing Inspections 10
  • 12. What is a medical device? Defined in s41BD of the Therapeutic Goods Act 1989 1 (a) Any instrument, apparatus, appliance, material or other article intended to be used for human beings for the purpose of one or more of the following (i) diagnosis, prevention, monitoring, treatment or alleviation of disease; (ii) diagnosis, monitoring, treatment, alleviation of or compensation for an injury or disability (iii) investigation, replacement or modification of the anatomy or of a physiological process (iv) control of conception; and that does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but that may be assisted in its function by such means Bandages Dental implant Breast implant Glucose monitor 11
  • 13. What is a medical device? (continued) Defined in s41BD of the Therapeutic Goods Act 1989 (2) For the purposes of paragraph (1)(a), the purpose for which an instrument, apparatus, appliance, material or other article (the main equipment) is to be used is to be ascertained from the information supplied, by the person under whose name the main equipment is or is to be supplied, on or in any one or more of the following: (a) the labelling on the main equipment; (b) the instructions for using the main equipment; (c) any advertising material relating to the main equipment; (d) technical documentation describing the mechanism of action of the main equipment. 12
  • 14. Risk based classification Risk classification is based on: Intended use of the device Potential to Harm patients, users and other persons Degree of invasiveness in the human body Location and Duration of use 13
  • 15. Regulatory oversight increases with increasing risk category Regulatory Scrutiny ✔✔✔✔ ✔✔✔ ✔✔ ✔ Class III Class IIb Class IIa Class ILow Risk High Risk (IVD Device Classes – Class 1 to Class 4)
  • 16. The Essential Principles General principles 1. Use of medical devices not to compromise health and safety 2. Design and construction of medical devices to conform to safety principles 3. Medical devices to be suitable for intended purpose 4. Long-term safety 5. Medical devices not to be adversely affected by transport or storage 6. Benefits of medical devices to outweigh any side effects Principles about design and construction 7. Chemical, physical and biological properties 8. Infection and microbial contamination 9. Construction and environmental properties 10.Medical devices with a measuring function 11.Protection against radiation 12.Medical devices connected to or equipped with an energy source 13.Information to be provided with medical devices 14.Clinical evidence 15.Principles applying to IVD medical devices only Therapeutic Goods (Medical Devices) Regulations 2002, Schedule 1 www.legislation.gov.au 15
  • 17. What is clinical evidence for a medical device? https://www.tga.gov.au/sites/default/files/clinical-evidence-guidelines-medical-devices.pdf 16
  • 18. Inclusion in the ARTG Class I: Self-assessment and declaration Class Is, Im, IIa: Manufacturing certification including technical file review Class IIb: Manufacturing certification including technical file review Mandatory application audit for some Class IIb devices Class III: Manufacturing certification Device design examination certification Mandatory application audit Evidence requirements
  • 19. Postmarket obligations Monitoring of product performance Adverse event reporting to the TGA For higher risk devices: AIMD, Class III or implantable Class IIb device Annual reports to the TGA required Environmental scanning Review of medical & scientific literature, regulatory news, media and other sources
  • 20. 19 • What are digital medical devices? • What is the Role of the Regulator? • What are the Challenges in Applying the Framework to Digital Devices? • What are Some International Approaches? • What is the TGA doing? • Questions
  • 21. Is it regulated as a medical device? A product is regulated by the TGA when it meets the definition of a medical device. That is, when the legal manufacturer intends for the product to be used for:  diagnosis,  prevention,  monitoring,  treatment, or  alleviation, of disease, injury or disability Software is regulated by the TGA… • When it is part of a hardware medical device or medical device system • When it controls a medical device • When it meets the definition of a medical device. 20
  • 22. Software as a Medical Device (SaMD) Software that is intended to run on general purpose computing platforms and is also a medical device1 • Platforms could include computers, tablets, phones, web browsers • Examples: – Image processing for diagnosis or pathology – Software that collects information and makes a clinical decision or referral – Apps that calculate drug dose 1. As defined in 41BD of the Therapeutic Goods Act 1989. 21
  • 23. Software as a Medical Device (SaMD) • Does not include: – general health and lifestyle apps (not a MD) – software that is part of a device (not regulated separately) – apps that control a medical device (accessory and MD) – apps that rely on hardware in addition to a general purpose computing platform, eg – sensors, to achieve their intended purpose 22
  • 24. Current classification rules for software 4.1 Active medical devices - general An active medical device is classified as Class I, unless the device is classified at a higher level under another clause in this Part or in Part 2, 3 or 5. Regulation 3.3 (5) If a medical device is driven, or influenced, by an item of software, the software has the same classification as the medical device. Most software is Class I under the current rules 23
  • 25. Challenges for regulating DTC digital devices • Gaps in the current framework • Interpretation of ‘intended purpose’ to determine regulatory status • “Off-label use” of medical-device-like consumer goods • Consumer expectation for medical device = consumer good • New industry players unfamiliar with medical device regulation • Variable levels of consumer health literacy 24
  • 26. 25 • What are digital medical devices? • What is the Role of the Regulator? • What are the Challenges in Applying the Framework to Digital Devices? • What are Some International Approaches? • What is the TGA doing? • Questions
  • 28. International digital device regulation Recent Regulatory Reforms • Europe – Higher Classification for Software that provides information for clinical decision making, – New general safety and performance requirements for software • FDA – New medical device definition with details for software – Premarket assessment and certification of manufacturers for software products • Australia – Recent consultation for regulatory reforms for software 27
  • 29. New requirements in Europe • The EU MDR 2017/745 has introduced the following new classifications for software: • Software that provides information to be used in making decisions for diagnosis or treatment is: – Class III if the decisions have an impact that may cause death or an irreversible deterioration of a person’s state of health – Class IIb if the decisions have an impact that may cause a serious deterioration of a person’s state of health or a surgical intervention – Class IIa in any other case NOTE: The EU already has an additional classification rule applicable to software compared with Australia: Rule 16 (MDD 93/42/EEC) Devices specifically intended for recording of X-ray diagnostic images are in Class IIa. 28
  • 30. New requirements in the USA 29
  • 31. New requirements in the USA https://www.fda.gov/medicaldevices/digitalhealth/digitalhealthprecertprogram/default.htm#program 30
  • 32. • What are digital medical devices? • What is the Role of the Regulator? • What are the Challenges in Applying the Framework to Digital Devices? • What are Some International Approaches? • What is the TGA doing? • Questions 31
  • 33. Proposed new requirements in Australia • New rules to appropriately classify SaMD products according to the potential harm they could cause to patients • Exclude SaMD products from the personal importation provisions so that SaMD products will be required to be included in the ARTG and have an Australian sponsor • Ensure the essential principles for medical devices include clear and transparent requirements for demonstrating the safety and performance of SaMD and other regulated software. https://www.tga.gov.au/consultation/consultation-regulation-software-including-software-medical-device-samd 32
  • 34. Next steps Consultation on software reforms • Consultation 14 February to 31 March 2019 • 41 Submissions, broad support for the proposals • Revised proposals based on feedback • Stakeholder workshop 24 June 2019 for additional feedback • Policy approval • Drafting, approval and publication of regulations • Identify carve outs for certain software categories • Stakeholder engagement and education • Regulatory guidance for new legislation 33
  • 35. Website references and contacts Medical device regulation basics: http://www.tga.gov.au/medical-devices-regulation-basics Regulation of Software as a Medical Device (SaMD): https://www.tga.gov.au/regulation-software-medical-device Premarket medical device enquiries: devices@tga.gov.au The TGA’s Digital Devices team: digital.devices@tga.gov.au 34

Editor's Notes

  1. What is the role of the regulator? Apply risk-based regulatory oversight to medical devices to provide a reasonable assurance that the device is safe and will perform as intended